Inactief instrument

Andere talen Arbutus Biopharma Corp Nasdaq

Aandelen

CA87911B2093

slotkoers Nasdaq Andere beurzen
- ^USD	-

22:00	Sectorupdate: Gezondheidszorgaandelen eind van de middag gemengd	MT
19:55	Sectorupdate: Aandelen gezondheidszorg vrijdagmiddag zachter	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Sector Update: Health Care Stocks Mixed Late Afternoon	22:00
Sector Update: Health Care Stocks Softer Friday Afternoon	19:55
Arbutus Biopharma Urged to Stop Share Issuances, Explore Alternatives for Hepatitis B Program	18:04
Arbutus Biopharma Urged to Stop Share Issuances, Explore Alternatives for Hepatitis B Program	16:41
Whitefort Capital Publishes Open Letter to Arbutus Biopharma Shareholders Outlining Paths to Maximize Value	15:03
Investor Whitefort urges Arbutus Biopharma to halt stock sales, find partner	14:00
Whitefort Capital Management Engages with Arbutus Biopharma	09/05
Arbutus to Participate in Two Upcoming Investor Conferences	07/05
Arbutus Biopharma : Corporate Presentation - May 2024	02/05
Earnings Flash (ABUS) ARBUTUS BIOPHARMA CORPORATION Posts Q1 Revenue $1.5M	02/05
Earnings Flash (ABUS) ARBUTUS BIOPHARMA CORPORATION Posts Q1 Revenue $1.5M, vs. Street Est of $3.7M	02/05
Arbutus: Q1 Earnings Snapshot	02/05
Arbutus Biopharma Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	02/05
Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update	02/05
Arbutus Announces Retirement of Chief Scientific Officer, Michael J. Sofia, PhD, Effective December 31, 2024	02/05
Arbutus Biopharma Corporation Announces Retirement of Chief Scientific Officer, Michael J. Sofia Effective December 31, 2024	02/05
Arbutus to Report First Quarter 2024 Financial Results and Provide Corporate Update	18/04
Arbutus Biopharma : Corporate Presentation - April 2024	15/04
Arbutus Biopharma Obtains Favorable Court Order in Moderna Patent Lawsuit	05/04
Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Against Moderna	04/04

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Arbutus Biopharma Corp Nasdaq

Aandelen

CA87911B2093

Andere talen

Filters